Literature DB >> 7500840

Molecular cloning of a cDNA for the human inositol 1,4,5-trisphosphate receptor type 1, and the identification of a third alternatively spliced variant.

F C Nucifora1, S H Li, S Danoff, A Ullrich, C A Ross.   

Abstract

The Inositol 1,4,5-trisphosphate receptor (IP3R) is an intracellular calcium channel involved in coupling cell membrane receptors to calcium signal transduction pathways within the cell. We have cloned a cDNA for the human type 1 inositol 1,4,5-trisphosphate receptor. The sequence contains the S2 splice site which appears to be the region most divergent between rat and human. We now report an additional alternatively spliced region in the coupling domain, that is 9 amino acids long, which we term S3. Alternatively spliced forms are found in both human and rat. PCR analysis of brain and peripheral tissues from human and rat shows both transcripts of the type 1 inositol 1,4,5-trisphosphate receptor in all tissues. The long form predominates in most brain regions (except the cerebellum) while the short form predominates in peripheral tissues. The sequence of the longer form in human appears to create an additional consensus protein kinase C phosphorylation site.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7500840     DOI: 10.1016/0169-328x(95)00089-b

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  18 in total

Review 1.  Inositol trisphosphate receptors in smooth muscle cells.

Authors:  Damodaran Narayanan; Adebowale Adebiyi; Jonathan H Jaggar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

Review 2.  Inositol trisphosphate receptor Ca2+ release channels.

Authors:  J Kevin Foskett; Carl White; King-Ho Cheung; Don-On Daniel Mak
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

Review 3.  Control of alternative pre-mRNA splicing by Ca(++) signals.

Authors:  Jiuyong Xie
Journal:  Biochim Biophys Acta       Date:  2008-01-17

Review 4.  Protein-protein interactions in intracellular Ca2+-release channel function.

Authors:  J J MacKrill
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

5.  Recessive and Dominant De Novo ITPR1 Mutations Cause Gillespie Syndrome.

Authors:  Sylvie Gerber; Kamil J Alzayady; Lydie Burglen; Dominique Brémond-Gignac; Valentina Marchesin; Olivier Roche; Marlène Rio; Benoit Funalot; Raphaël Calmon; Alexandra Durr; Vera Lucia Gil-da-Silva-Lopes; Maria Fernanda Ribeiro Bittar; Christophe Orssaud; Bénédicte Héron; Edward Ayoub; Patrick Berquin; Nadia Bahi-Buisson; Christine Bole; Cécile Masson; Arnold Munnich; Matias Simons; Marion Delous; Helene Dollfus; Nathalie Boddaert; Stanislas Lyonnet; Josseline Kaplan; Patrick Calvas; David I Yule; Jean-Michel Rozet; Lucas Fares Taie
Journal:  Am J Hum Genet       Date:  2016-04-21       Impact factor: 11.025

6.  Effect of mutation of a calmodulin binding site on Ca2+ regulation of inositol trisphosphate receptors.

Authors:  X Zhang; S K Joseph
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

Review 7.  Ca2+-signaling, alternative splicing and endoplasmic reticulum stress responses.

Authors:  Joachim Krebs; Jody Groenendyk; Marek Michalak
Journal:  Neurochem Res       Date:  2011-03-02       Impact factor: 3.996

8.  Nuclear ALG-2 protein interacts with Ca2+ homeostasis endoplasmic reticulum protein (CHERP) Ca2+-dependently and participates in regulation of alternative splicing of inositol trisphosphate receptor type 1 (IP3R1) pre-mRNA.

Authors:  Kanae Sasaki-Osugi; Chiaki Imoto; Terunao Takahara; Hideki Shibata; Masatoshi Maki
Journal:  J Biol Chem       Date:  2013-09-27       Impact factor: 5.157

9.  Localization of type I inositol 1,4,5-triphosphate receptor in the outer segments of mammalian cones.

Authors:  T L Wang; P Sterling; N Vardi
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

10.  Muscle-specific mRNA isoform encodes a protein composed mainly of the N-terminal 175 residues of type 2 Ins(1,4,5)P3 receptor.

Authors:  A Futatsugi; G Kuwajima; K Mikoshiba
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.